211At-OTSA101

N/A

Report date: 2025/11/10 17:58:36

Base Information

Drug Name211At-OTSA101

Drug Alias Name211At-OTSA101

ClassificationRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionAnti-FZD10

TargetsFrizzled-10

Therapy Area/IndicationsSarcoma, Synovial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOncotherapy Science, Inc

China Registration ClassN/A

Develop Information

Active CompaniesOncotherapy Science, Inc

Inactive CompaniesN/A

Active IndicationsSarcoma, Synovial

Inactive IndicationsN/A

Other Information

ATC CodeN/A